Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Ocular diseases such as diabetic retinopathy (DR) and uveitis are associated with injury to the blood–retinal barrier (BRB). Whereas high glucose (HG) and advanced glycation end products (AGE) contribute to DR, bacterial infections causing uveitis are triggered by endotoxins such as lipopolysaccharide (LPS). It is unclear how HG, AGE, and LPS affect human retinal endothelial cell (HREC) junctions. Moreover, tumor necrosis factor-α (TNFα) is elevated in both DR and ocular infections. In the current study, we determined the direct effects of HG, AGE, TNFα, and LPS on the expression and intracellular distribution of claudin-5, VE-cadherin, and β-catenin in HRECs and how these mediators affect Akt and P38 MAP kinase that have been implicated in ocular pathologies. In our results, whereas HG, AGE, and TNFα activated both Akt and P38 MAPK, LPS treatment suppressed Akt but increased P38 MAPK phosphorylation. Furthermore, while treatment with AGE and HG increased cell-junction protein expression in HRECs, LPS elicited a paradoxical effect. By contrast, when HG treatment increased HREC-barrier resistance, AGE and LPS stimulation compromised it, and TNFα had no effect. Together, our results demonstrated the differential effects of the mediators of diabetes and infection on HREC-barrier modulation leading to BRB injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“human retinal endothelial cells also respond to LPS in vitro with increased p38 phosphorylation [ 184 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [184]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinmetz, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30489-7 · Cited by 3,189
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673 · cited 1×
“with HG and AGE in diabetes has been demonstrated [57,58], targeting Akt was suggested as a therapeutic strategy to treat DR [59].”
BackgroundRecognition of lipopolysaccharide pattern by TLR4 complexes
Park, B. S., & Lee, J.-O. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.97 · Cited by 1,234 · cited 1×
“The literature indicates that knocking down TLR4, a receptor for LPS [69], results in increased ZO-1 and occludin levels in RECs subjected to HG [70], implying that TLR4 may be directly involved in REC-barrier regulation [34,71].”
BackgroundDiabetic Retinopathy: A Position Statement by the American Diabetes Association
Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017) · Diabetes Care · doi:10.2337/dc16-2641 · Cited by 940
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722 · cited 2×
“Retinal vascular hyperpermeability occurs through various stimuli, leading to edema and breakdown of BRB [27].”
BackgroundEelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572 · cited 1×
“The differences in the expression profiles of proangiogenic factors, cytokines, and TJ proteins seem to be dictated by the origin of ECs relating to their vascular bed [15,16].”
BackgroundCunha-Vaz, J., Bernardes, R., & Lobo, C. (2011) · European Journal of Ophthalmology · doi:10.5301/ejo.2010.6049 · Cited by 539
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
Chen, J., Somanath, P. R., Razorenova, O., Chen, W. S., Hay, N., Bornstein, P., & Byzova, T. V. (2005) · Nature Medicine · doi:10.1038/nm1307 · Cited by 456 · cited 3×
“Although it is known that Akt inhibition will result in the loss of barrier integrity [36], overexpression of Akt (myrAkt) has also proven to cause retinal vascular malformations [54].”
BackgroundSelf-citationAdvanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423 · cited 1×
“Deposition of AGE adducts in mice induced REC-barrier disruption and retinal capillary hyperpermeability [31,62] through VEGF production [63], suggesting AGE might be a better candidate to mimic DR effects in ECs in culture.”
BackgroundAveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A. (2010) · Diabetes · doi:10.2337/db09-1606 · Cited by 403 · cited 2×
“TNFα has been shown to induce REC permeability by reducing the expression of TJ proteins through activation of PKCζ and NF-κB [32].”
BackgroundMethod
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“It has been shown that human retinal endothelial cells also respond to LPS in vitro with increased p38 phosphorylation [184], and induction of experimental uveitis by LPS in vivo activated ERK on MG cells which was resolved by dexamethasone treatment [185].”
BackgroundFerreira, L. B., Williams, K. A., Best, G., Haydinger, C. D., & Smith, J. R. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1479 · Cited by 55
Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms
Selim, M. S., Matani, B. R., Henry-Ojo, H. O., Narayanan, S. P., & Somanath, P. R. (2025) · Cells · doi:10.3390/cells14171346 · Cited by 40
“In human retinal endothelial cells (HRECs) exposed to HG, Cldn5 expression is reduced compared to normal glycemic conditions, resulting in increased para-cellular permeability [45,103].”
InfluentialSelf-citationShan, S., Liu, F., Ford, E., Caldwell, R. B., Narayanan, S. P., & Somanath, P. R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114714 · Cited by 19
“These results, combined with our previous report in HRECs in vitro [18], suggest that upregulation of Cldn5 expression could be pathological in PR and that TCBN treatment can prevent it.”
InfluentialSelf-citationEffects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells
Ferreira, L. B., Ashander, L. M., Ma, Y., Appukuttan, B., Williams, K. A., Best, G., & Smith, J. R. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156407 · Cited by 24
Metadata
- Authors
- Rudraraju, M., Narayanan, S. P., & Somanath, P. R.
- Affiliations
- University of Georgia (US)
- Corresponding author
- Narayanan, S. Priya
- Somanath, Payaningal R.
- Venue
- Life
- Publisher
- MDPI AG
- Published
- 2021-12-27
- Volume
- 12
- Issue
- 1
- Pages
- 33
- ISSN
- 2075-1729 (ISSN-L)
- PMC
- PMC8779223
- OpenAlex
- W4200529658
- Cited by
- 15
- References
- 75
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 6
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01EY028569)
- National Center for Advancing Translational Sciences (UL1TR002378)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- blood-retinal barrier, retinal endothelial cells, diabetic retinopathy, uveitis, high glucose, advanced glycation end products, lipopolysaccharide, TNF-α, claudin-5, VE-cadherin, β-catenin, cell junctions, Akt signaling, p38 MAPK, barrier permeability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis. https://app.cochat.ai/papers/10.3390/life12010033
- The paper
- Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2021). Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis. Life. https://doi.org/10.3390/life12010033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.